# Chris Geisler

> Chris Geisler is a pre-seed investor backing Medical and Women's. See 1 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Total investments: 1
- Last investment: Jan 2022
- Lead investor: 100%
- Last updated: Oct 2026

Chris Geisler is a pre-seed investor focused on Medical and Women's.

## Contacts

5 contacts available for Chris Geisler: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/chris-geisler-1fdb?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Women's | 1 | 100% |
| mHealth | 1 | 100% |
| Wellness | 1 | 100% |
| Nutrition | 1 | 100% |

10 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Fluid Medical | Fluid Medical develops Oria, a consumer health intelligence platform that turns a 90-second at-home urine test into a clinical-grade view of the body — read by the user's smartphone camera, with no separate reader hardware required. Oria is built on a 4-layer data architecture: Layer 1 captures urine biomarkers; Layer 2 (DailySignal) ingestscontinuous wearable physiology (HRV, sleep, skin temperature, SpO2); Layer 3 (Year 2) adds cultural and dietary context that transforms generic biomarker interpretation into personalized intelligence; Layer 4 (Year 2) integrates the user's clinical history. The Day-1 product is Oria Foundational — a 9-marker wellness panel covering hydration, electrolytes, vitamins, ketones, microbiome indicators, and inflammatory baseline, positioned under FDA General Wellness Guidance for direct-to-consumer launch. From this foundation, the company expands through five product tiers over 2027–2029: women's hormonal health, men's androgen monitoring, GLP-1 and metabolic health, gut health, mental health, longevity, and Oria Sentinel — a CLIA-lab clinical pathway for early cancer surveillance. Fluid Medical is the Healthcare vertical of Fluid Scientific, a sovereign-data platform company headquartered in Vancouver, BC. First market launch is the United Arab Emirates (MOHAP wellness panel registration in progress), leveraging Federal Law No. 2 of 2019 to position the platform as the world's most credible jurisdiction for personal health data. US operations will run through a planned Delaware sub-entity (Fluid Precision Inc) for clinical pathways and ARPA-H contracting. Fluid Medical Ltd was incorporated in 2024 as the operating subsidiary of Fluid Scientific Development Limited (Vancouver, est. 2022). The company acquired the entirety of Vessel Health, Inc.'s intellectual property — patents, trademarks, and product technology — in February 2025 via a UCC foreclosure sale recorded with USPTO. Approximately US$1.9M of founder and Family & Friends capital has been deployed across the platform to date. The company is currently raising pre-seed capital and pursuing non-dilutive funding including ARPA-H FY26 SBIR/STTR (Topic 1, Women's Health Diagnostics), Hub71+ Life Sciences Cohort 20, and TAQADAM at KAUST. | $1.9M | Pre-Seed | Jan 30, 2022 | https://fluidmedical.com |

1 of 1 investments shown.

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Business Development Bank of Canada](https://shizune.co/investors/profile/business-development-bank-of-canada) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors in Canada](https://shizune.co/investors/medical-device-angel-investors-canada)

## FAQ

### What does Chris Geisler invest in?

Chris Geisler invests primarily in Medical, Women's and mHealth startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Chris Geisler?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Chris Geisler last invest?

The most recent investment recorded for Chris Geisler closed in Jan 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co